The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature.

Berman, Mark; Ben-Ami, Ronen; Berliner, Shlomo; Anouk, Marina; Kaufman, Ilana; Broyde, Adi; Borok, Sara; Elkayam, Ori

Berman, Mark; Ben-Ami, Ronen; Berliner, Shlomo; Anouk, Marina; Kaufman, Ilana; Broyde, Adi; Borok, Sara; Elkayam, Ori.

Afiliación

Berman M; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Ben-Ami R; Infectious Disease Unit, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Berliner S; Tel Aviv Medical Center, Internal Medicine E Department, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Anouk M; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Kaufman I; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Broyde A; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Borok S; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Elkayam O; Department of Rheumatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

Life (Basel) ; 11(3)2021 Mar 20.

Article en En | MEDLINE | ID: mdl-33804790

Palabras clave

C-reactive protein; giant cell arteritis; infection; inflammation; rheumatoid arthritis; tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google